Interestingly, one study reported a higher incidence of DNA methylation in PGR promoter in HER2-amplified/overexpressing cases, pointing to the role of methylation in the pathogenesis of ER(+)/PgR(−)/HER2(+) breast tumors [59]. Here, ERBB2 is linked to breast neoplasm.